Published in Arch Mal Coeur Vaiss on July 01, 1993
The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47
Replacement of the Bacillus subtilis subtilisin structural gene with an In vitro-derived deletion mutation. J Bacteriol (1984) 5.03
Characterization of the spo0A locus and its deduced product. Proc Natl Acad Sci U S A (1985) 4.86
Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat Struct Biol (1999) 4.37
The ECG in pulmonary embolism. Predictive value of negative T waves in precordial leads--80 case reports. Chest (1997) 4.29
Cloning, sequencing, and secretion of Bacillus amyloliquefaciens subtilisin in Bacillus subtilis. Nucleic Acids Res (1983) 3.70
Cloning of the neutral protease gene of Bacillus subtilis and the use of the cloned gene to create an in vitro-derived deletion mutation. J Bacteriol (1984) 3.41
Chromosomal location of a Bacillus subtilis DNA fragment uniquely transcribed by sigma-28-containing RNA polymerase. J Bacteriol (1982) 2.82
Cloning structural gene sacB, which codes for exoenzyme levansucrase of Bacillus subtilis: expression of the gene in Escherichia coli. J Bacteriol (1983) 2.73
Localization of Bacillus subtilis sacU(Hy) mutations to two linked genes with similarities to the conserved procaryotic family of two-component signalling systems. J Bacteriol (1988) 2.71
Studies of sigma D-dependent functions in Bacillus subtilis. J Bacteriol (1990) 2.53
Paternal concentrations of dioxin and sex ratio of offspring. Lancet (2000) 2.47
Isolation of Bacillus subtilis genes from a charon 4A library. J Bacteriol (1981) 2.45
Travel as a risk factor for venous thromboembolic disease: a case-control study. Chest (1999) 2.34
Identification of the pleiotropic sacQ gene of Bacillus subtilis. J Bacteriol (1986) 2.33
Effect of stage 0 sporulation mutations on subtilisin expression. J Bacteriol (1986) 2.31
De novo initiation of RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase. J Virol (2000) 2.19
Biochemical and functional comparison of DNA polymerases alpha, delta, and epsilon from calf thymus. J Biol Chem (1991) 2.08
Laparoscopic repair of incisional hernia: a retrospective study of 159 patients. Surg Endosc (2001) 2.02
Generation of large libraries of random mutants in Bacillus subtilis by PCR-based plasmid multimerization. Biotechniques (1997) 2.01
Characterization of lexB mutations in Escherichia coli K-12. J Bacteriol (1977) 1.99
A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. N Engl J Med (1997) 1.97
Rapid identification of high affinity peptide ligands using positional scanning synthetic peptide combinatorial libraries. Biotechniques (1992) 1.89
Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause? Gut (2001) 1.88
Exogenous lipoid pneumonia: HRCT, MR, and pathologic findings. Eur Radiol (1999) 1.86
The genetic characterization of lexB32, lexB33 and lexB35 mutations of Escherichia coli: location and complementation pattern for UV resistance. Mol Gen Genet (1977) 1.83
Doppler study of mesenteric, hepatic, and portal circulation in alcoholic cirrhosis: relationship between quantitative Doppler measurements and the severity of portal hypertension and hepatic failure. Hepatology (1998) 1.81
[Anesthesia consultation in cardiovascular and thoracic surgery. A survey of patient and physician satisfaction]. Ann Fr Anesth Reanim (1999) 1.79
Location of the targets of the hpr-97, sacU32(Hy), and sacQ36(Hy) mutations in upstream regions of the subtilisin promoter. J Bacteriol (1988) 1.74
Cloning and localization of the lepidopteran protoxin gene of Bacillus thuringiensis subsp. kurstaki. Proc Natl Acad Sci U S A (1982) 1.71
Effect of paraoxonase-1 polymorphism on clinical outcomes in patients treated with clopidogrel after an acute myocardial infarction. Clin Pharmacol Ther (2011) 1.67
Straight hair associated with interferon-alfa plus ribavirin in hepatitis C infection. Br J Dermatol (2002) 1.66
Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism. Gut (1999) 1.66
Template/primer requirements and single nucleotide incorporation by hepatitis C virus nonstructural protein 5B polymerase. J Virol (2000) 1.63
Characterization of the levanase gene of Bacillus subtilis which shows homology to yeast invertase. Mol Gen Genet (1987) 1.58
Impact of attenuation correction by simultaneous emission/transmission tomography on visual assessment of 201Tl myocardial perfusion images. J Nucl Med (1999) 1.57
Work disability in adults with cystic fibrosis. Am J Respir Crit Care Med (1995) 1.56
Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol (2004) 1.56
Characterization and mapping of the Bacillus subtilis prtR gene. J Bacteriol (1987) 1.55
Diagnostic and therapeutic aspects of endoscopic retrograde cholangiography in papillomatosis of the bile ducts: analysis of five cases. Gastrointest Endosc (1997) 1.54
Respiratory effects of occupational exposure to aerosolized pentamidine. J Occup Environ Med (1995) 1.48
Early metabolic acidosis and coma after acetaminophen ingestion. Ann Emerg Med (1999) 1.46
alpha-Interferon therapy for congenital dyserythropoiesis type I. Br J Haematol (1995) 1.46
Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis. J Hepatol (1997) 1.45
Cardiovascular rehabilitation in patients with diabetes. J Cardiopulm Rehabil Prev (2010) 1.41
[Precaution in the thrombolytic treatment of myocardial infarction]. Presse Med (1989) 1.40
Laparoscopic vertical banded gastroplasty. A multicenter prospective study of 200 procedures. Surg Endosc (2006) 1.40
[Hydrops fetalis associated with Noonan syndrome]. Pediatrie (1991) 1.39
Intrapericardial bronchogenic cyst: an unusual cause of CA 19-9 increase. Eur J Med (1992) 1.39
[Severe early pulmonary embolism after blockage of the vena cava]. Presse Med (1994) 1.39
Enzymatic characterization of hepatitis C virus NS3/4A complexes expressed in mammalian cells by using the herpes simplex virus amplicon system. J Virol (1996) 1.38
[Duration of antivitamin K therapy in venous thromboembolic disease]. Arch Mal Coeur Vaiss (1995) 1.38
Prenatal diagnosis of lobar bronchial atresia. Ultrasound Obstet Gynecol (2011) 1.38
Prophage induction and cell division in E. coli. V. Dominance and complementation analysis in partial diploids with pleiotropic mutations (tif, recA, zab and lexB) at the recA locus. Mol Gen Genet (1977) 1.38
Mutational analysis of bovine viral diarrhea virus RNA-dependent RNA polymerase. J Virol (1999) 1.37
The use of medicinal herbs by human immunodeficiency virus-infected patients. Arch Intern Med (1991) 1.30
Interactions of pathogenic Neisseria with host cells. Is it possible to assemble the puzzle? Mol Microbiol (1999) 1.30
p38alpha blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1alpha- to FoxO-dependent transcription. Cell Death Differ (2009) 1.30
Correlation between Bacillus subtilis scoC phenotype and gene expression determined using microarrays for transcriptome analysis. J Bacteriol (2001) 1.26
Molecular cloning of the spo0B sporulation locus in bacteriophage lambda. J Bacteriol (1982) 1.23
The X-ray structure of a recombinant major urinary protein at 1.75 A resolution. A comparative study of X-ray and NMR-derived structures. Acta Crystallogr D Biol Crystallogr (2001) 1.20
Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial. J Hepatol (1998) 1.20
Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations. Br J Anaesth (1999) 1.19
Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension. Eur J Gastroenterol Hepatol (1999) 1.19
Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans. Br J Dermatol (2005) 1.19
SCH 48973: a potent, broad-spectrum, antienterovirus compound. Antimicrob Agents Chemother (1997) 1.17
Genetic and enzymic studies on the recombination process in Bacillus subtilis. Mol Gen Genet (1975) 1.16
[Treatment of primary cardiogenic shock by coronary transluminal angioplasty during the acute phase of myocardial infarction]. Arch Mal Coeur Vaiss (1990) 1.14
Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med (2000) 1.13
Dihydroorotate dehydrogenase is a high affinity binding protein for A77 1726 and mediator of a range of biological effects of the immunomodulatory compound. J Biol Chem (1995) 1.13
Four different DNA helicases from calf thymus. J Biol Chem (1992) 1.10
Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice. Cancer Res (1998) 1.10
Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: benefit of oral anticoagulants. J Am Coll Cardiol (1999) 1.10
Effectiveness of a manual disinfection procedure in eliminating hepatitis C virus from experimentally contaminated endoscopes. Gastrointest Endosc (1999) 1.09
Capillary electrophoresis-single-strand conformation polymorphism analysis for rapid identification of Pseudomonas aeruginosa and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol (1999) 1.08
Novel immunoblot assay using four recombinant antigens for diagnosis of Epstein-Barr virus primary infection and reactivation. J Clin Microbiol (1999) 1.08
Genetic contribution to idiopathic adult-onset blepharospasm and cranial-cervical dystonia. Eur Neurol (1993) 1.07
Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clin Microbiol Infect (2011) 1.06
Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial. Pediatrics (2001) 1.06
Physician reports of work-related asthma in California, 1993-1996. Am J Ind Med (2001) 1.06
Resistance of human nucleotide excision repair synthesis in vitro to p21Cdn1. Oncogene (1998) 1.06
Seroprevalence of HSV-1 and HSV-2 infection in the general French population. Sex Transm Infect (2002) 1.05
[A clinical form of angina pectoris: Prinzmetal's angor]. Sem Hop (1969) 1.04
Indocyanine green angiography in central serous chorioretinopathy. ICG angiography in CSC. Int Ophthalmol (1997) 1.04
Thyroid function in physiological aging and in centenarians: possible relationships with some nutritional markers. Metabolism (2002) 1.04
Nucleotide sequence of the outB locus of Bacillus subtilis and regulation of its expression. J Bacteriol (1987) 1.03
[Ileocecal intussusception secondary to a cecal endometriosis]. J Gynecol Obstet Biol Reprod (Paris) (2008) 1.03
Studies on transduction process by SPP1 phage. J Gen Virol (1978) 1.03
Calf thymus DNA polymerase delta independent of proliferating cell nuclear antigen (PCNA). Nucleic Acids Res (1989) 1.03
Cytomegalovirus seroprevalence in French pregnant women: parity and place of birth as major predictive factors. Eur J Epidemiol (1998) 1.03
Dihydroorotate dehydrogenase is a target for the biological effects of leflunomide. Transplant Proc (1996) 1.02